CEFTRIAXONE AND DEXTROSE
- Product NDC
- 0264-3155
- 11-digit product format
- 002643155
- Labeler code
- 0264
- Product ID
- 0264-3155_05bf8d04-202d-472f-94b5-4f5d9020f0c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CEFTRIAXONE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- B. Braun Medical Inc.
- Application
- NDA050796
- Marketing category
- NDA
- Marketing start
- 2005-04-20
- Substance
- CEFTRIAXONE SODIUM
- Active strength
- 2 g/50mL
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | CEFTRIAXONE SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 |
| N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | CEFTRIAXONE SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N050796-001 | AP |
| N050796-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N050796-001 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N050796-002 | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 2005-04-20 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N050796-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N050796-002 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N050796-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N050796-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050796-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050796-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N050796-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N050796-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050796-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050796-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050796-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050796-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050796-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050796-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050796-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050796-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050796-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050796-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050796-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050796-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N050796-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N050796-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050796-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050796-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050796-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050796-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050796-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050796-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N050796-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N050796-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050796-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050796-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N050796-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N050796-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N050796-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N050796-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N050796-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N050796-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N050796-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N050796-002 | AP | 1 | bb7c543d1eb4… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEFTRIAXONE AND DEXTROSE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CEFTRIAXONE SODIUM | 2 g/50mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 023Z5BR09K | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 67153914-16bc-490d-82d7-638061618467 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cb89b86a-369e-4204-8910-ae797c503af3 | Product name | 1 | 20230706 |
| 67ae10d0-6c6a-4d52-a629-da83321859b9 | Product name | 3 | 20190201 |
| d4880ace-a516-8c47-8dfd-73a4ba5887d7 | Product name | 2 | 20180830 |
| 01b0d089-049b-4c6d-8dfe-1bffad9be307 | Product name | 2 | 20180807 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 2d5083fe-71de-4fce-8d67-e9049cba775c | Product name | 1 | 20150107 |
| 1037f4ca-3bea-c9c4-2af4-fa6387b0e81e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0264-3155-11 | CEFTRIAXONE AND DEXTROSE | 24 in 1 CASE | INJECTION, SOLUTION | 24 | 36 | |
| 0264-3155-11 | CEFTRIAXONE AND DEXTROSE | 50 mL in 1 CONTAINER | INJECTION, SOLUTION | 50 | 36 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0264-3155-11 | EA - Each | 0264-3155 | e688ca49-87cf-483d-9eeb-a331ea20d4e4 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFTRIAXONE SODIUM | ACTIVE INGREDIENT | 023Z5BR09K | CEFTRIAXONE AND DEXTROSE (CEFTRIAXONE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 23 | |
| CEFTRIAXONE | ACTIVE MOIETY | 75J73V1629 | CEFTRIAXONE AND DEXTROSE (CEFTRIAXONE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 23 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | CEFTRIAXONE AND DEXTROSE (CEFTRIAXONE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 23 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CEFTRIAXONE AND DEXTROSE (CEFTRIAXONE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 23 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CEFTRIAXONE AND DEXTROSE | CEFTRIAXONE | B. Braun Medical Inc. | 67153914-16bc-490d-82d7-638061618467 | 2022-01-13 | Warnings, Adverse reactions | 050796 NDA050796 0264-3155 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1665021 | cefTRIAXone 1 GM Injection | PSN | 67153914-16bc-490d-82d7-638061618467 | 36 |
| 1665046 | cefTRIAXone 2 GM Injection | PSN | 67153914-16bc-490d-82d7-638061618467 | 36 |
| 1665021 | ceftriaxone 1000 MG Injection | SCD | 67153914-16bc-490d-82d7-638061618467 | 36 |
| 1665046 | ceftriaxone 2000 MG Injection | SCD | 67153914-16bc-490d-82d7-638061618467 | 36 |
| 1665021 | ceftriaxone 1 GM (as ceftriaxone sodium) Injection | SY | 67153914-16bc-490d-82d7-638061618467 | 36 |
| 1665046 | ceftriaxone 2 GM (as ceftriaxone sodium) Injection | SY | 67153914-16bc-490d-82d7-638061618467 | 36 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0264-3155-11 | 00264315511 | 24 CONTAINER in 1 CASE (0264-3155-11) / 50 mL in 1 CONTAINER | 24 container | 2005-04-20 | 0000-00-00 | No | No | Current |